|
The effect of isosorbide on gelatinase-A and gelatinase-B activity in leukemic cell lines
|
F. Hajighasmi   , A. Mirshafiey |
|
|
| Keywords: Key words : Isosorbide, Gelatinases, Leukemia |
|
|
Full-Text [PDF 475 kb]
(1922 Downloads)
| Abstract (HTML) (7247 Views)
|
Type of Study: Research |
Subject:
Imunohematology
Published: 2015/04/7
|
|
|
|
|
|
|
Full-Text: (2239 Views) |
References :
- Mehta V, Russin J, Spirtos A, He S, Adamczyk P, Amar AP, et al. Matrix Metalloproteinases in Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage. Neurol Res Int 2013; 2013: 943761.
- Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, et al. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One 2013; 8(5): e63165.
- Weng Y, Cai M, Zhu J, Geng J, Zhu K, Jin X, et al. Matrix metalloproteinase activity in early-stage lung cancer. Onkologie 2013; 36(5): 256-9.
- Yang Y, Thompson JF, Taheri S, Salayandia VM, McAvoy TA, Hill JW, et al. Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery. J Cereb Blood Flow Metab 2013; 33(7): 1104-14.
- Verslegers M, Lemmens K, Van Hove I, Moons L. Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system. Prog Neurobiol 2013; 105: 60-78.
- Hadler-Olsen E, Winberg JO, Uhlin-Hansen L. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 2013; 34(4): 2041-51.
- Selivanova SV, Stellfeld T, Heinrich TK, Mueller A, Krämer SD, Schubiger PA, et al. Design, synthesis and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9. J Med Chem 2013; 56(12): 4912-20.
- Naghavi N, de Mel A, Alavijeh OS, Cousins BG, Seifalian AM. Nitric oxide donors for cardiovascular implant applications. Small 2013; 9(1): 22-35.
- Levine AB, Punihaole D, Levine TB. Characterization of the role of nitric oxide and its clinical applications. Cardiology 2012; 122(1): 55-68.
- Freund Y, Delerme S, Boddaert J, Baker E, Riou B, Ray P. Isosorbide dinitrate bolus for heart failure in elderly emergency patients: a retrospective study. Eur J Emerg Med 2011; 18(5): 272-5.
- Mitchell JE, Ferdinand KC, Watson KE, Wenger NK, Watkins LO, Flack JM, et al. Treatment of heart failure in African Americans--a call to action. J Natl Med Assoc 2011; 103(2): 86-98.
- Xie K, Huang S. Contribution of nitric oxide-mediated
apoptosis to cancer metastasis inefficiency. Free Radic Biol Med 2003; 34(8): 969-86 .
- Vallance BA, Dijkstra G, Qiu B, van der Waaij LA, van Goor H, Jansen PL, et al. Relative contributions of
NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity. Am J Physiol Gastrointest Liver Physiol 2004; 287(4): G865-74.
- Martelletti P, Stirparo G, Morrone S, Rinaldi C, Giacovazzo M. Inhibition of intercellular adhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression in migraine patients. J Mol Med (Berl) 1997; 75(6): 448-53.
- Pipili-Synetos E, Papageorgiou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, et al. Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995; 116(2): 1829-34.
- Leblebisatan G, Antmen B, Saşmaz I, Kilinç Y. Vascular endothelial growth factor levels in childhood acute lymphoblastic and myeloblastic leukemia. Indian J Hematol Blood Transfus 2012; 28(1): 24-8.
- Chaudhary AK, Pandya S, Ghosh K, Nadkarni A. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview. Mutat Res 2013; 753(1): 7-23.
- Aricò A, Giantin M, Gelain M, Riondato F, Mortarino M, Comazzi S, et al. Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias. Vet J 2013; 196(2): 260-2.
- Moldeus P, Hogberg J, Orrenius S. Isolation and use of liver cells. Methods Enzymol 1978; 52: 60-71.
- Hajighasemi F, Hajighasemi S. Effect of Propranolol on Angiogenic Factors in Human Hematopoietic Cell Lines in vitro. Iran Biomed J 2009; 13(4): 223-8.
- Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of pictogram quantities of gelatinases. Anal Biochem 1994; 218(2): 325-9.
- Ledingham MA, Denison FC, Riley SC, Norman JE. Matrix metalloproteinases-2 and -9 and their inhibitors are produced by the human uterine cervix but their secretion is not regulated by nitric oxide donors. Hum Reprod 1999; 14(8): 2089-96.
- Hajighasemi F, Mirshafiey A. The effect of Isosorbide Dinitrate on vascular endothelial growth factor production by human leukemic cell lines in vitro.
TUMJ 2009; 66(12): 872-7. [Article in Farsi]
- Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274(31): 21491-4.
- Hijova E. Matrix metalloproteinases: their biological functions and clinical implications. Bratisl Lek Listy 2005; 106(3): 127-32.
- Hajighasemi F, Resvan Madani FZ. The effects of isosorbide dinitrate on in vitro proliferation of WEHI-164 cells and peripheral blood mononuclear cells. TUMJ 2012; 69(11): 671-7. [Article in Farsi]
- Näslund I, Norrby K. NO and de novo mammalian angiogenesis: further evidence that NO inhibits Bfgf-induced angiogenesis while not influencing VEGF165-induced angiogenesis. APMIS 2000; 108(1): 29-37.
- Parinandi NL, Sharma A, Eubank TD, Kaufman BF,Kutala VK, Marsh CB, et al. Nitroaspirin (NCX-4016), an NO donor, is antiangiogenic through induction of loss of redox-dependent viability and cytoskeletal reorganization in endothelial cells.
Antioxid Redox Signal 2007; 9(11): 1837-49.
- Zhang L, Shi J, Feng J, Klocker H, Lee C, Zhang J. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate Cancer Prostatic Dis 2004; 7(4): 327-32.
- Massari F, D'Andrea L, Cervo MA, Serra FP, Covelli V, Buscaino GA. Quantitative and qualitative modifications of lymphocyte subsets after sublingual administration of isosorbide dinitrate in migraineurs. Preliminary report. Acta Neurol (Napoli) 1994; 16(1-2): 11-8.
|
Sci J Iran Blood Transfus Organ 2015; 12(1): 46-54
|
|
The effect of isosorbide on gelatinase-A and
gelatinase-B activity in leukemic cell lines
Hajighasemi F.1, Mirshafiey A.2
1Department of Immunology, Faculty of Medicine, Shahed University, Tehran, Iran
2Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Background and Objectives
Gelatinases are a subgroup of matrix metalloproteinases (MMPs) and have an important role in tumor growth and angiogenesis. In this regard, MMP-2 (gelatinase A) and MMP-9 (gelatinase B) have particular value. Isosorbide dinitrate (a nitric oxide donor) has been broadly used in treatment of cardiac diseases and its inhibitory effect on angiogenesis and tumor growth have been reported in vivo. In this study, the effect of isosorbide dinitrate on gelatinase-A and gelatinase B activity in leukemic cell lines has been assessed in vitro.
Materials and Methods
MOLT-4, JURKAT and U937 leukemic cells were cultured in complete RPMI medium and then incubated with different concentrations of isosorbide (4 × 10 -7, 4 × 10 -6, 4 × 10 -5, 4 × 10 -4 M) in the presence of phorbol myristate acetate (PMA) (25 ng/mL), as a gelatinase inducer, for 24 hours. Afterwards, the gelatinase A and B activity in the cell culture medium was evaluated by gelatin zymography.
Results
The gelatinase A and B activity of MOLT-4, JURKAT and U937 leukemic cells treated with isosorbide did not show any significant difference with control. The gelatinase A activity was 1 ± 0.0 and 1.04 ± 0.06 in the control and 4 × 10 -4 M concentration of the isosorbide in MOLT-4 cell line, respectively.
Conclusions
In this study, isosorbide did not show any significant effect on gelatinase A and B activity in leukemic cells. The anti-tumoral and anti- angiogenic effect of isosorbide was reported by others to be possibly due to non-gelatinase activity mediated mechanism.
Key words: Isosorbide, Gelatinases, Leukemia
Received: 15 Feb 2014
Accepted: 17 Jan 2015
Correspondence: Hajighasemi F., PhD of Immunology. Associate Professor of Faculty of Medicine, Shahed University.
P.O.Box: 14155-7435, Tehran, Iran. Tel: (+9821) 88964792; Fax: (+9821) 88966310
E-mail: resoome@yahoo.com
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
|
.jpg)
.png)
